Just one dose of -- the compound in magic mushrooms -- alleviated anxiety and depression in cancer patients for up to five years. (Journal of Psychopharmacology)
Based on the ENLIGHTEN program, the Alkermes' application for its schizophrenia and bipolar disorder treatment ALKS 3831 (olanzapine/samidorphan) with an expected action date of November.
Although it was FDA approved in March 2019, esketamine nasal spray (Spravato) was for inclusion as a reimbursable drug in the U.K. by the National Institute for Health and Care Excellence (NICE) due to the safety profile. (BBC)
A Rhode Island cohort study found that girls received an roughly 1.5 years later on average than boys. (Autism Research)
may continue long after stopping treatment. "Some likely comfort themselves with the thought that once they stop treatment, they will get back to normal, when in fact they may be even less able to function," stated David Healy, MD, of Bangor University, writing in a commentary in the Journal of the Royal Society of Medicine.
A JAMA Psychiatry review outlined the historical origins for the , dating back to the 1700s.
"Virtual assistants" like Siri and Amazon's Alexa could aid people with struggling to quit. (npj Digital Medicine)
In her new Netflix documentary, revealed she battled an eating disorder. (CNN)
![author['full_name']](https://clf1.medpagetoday.com/media/images/author/kristenMonaco_188.jpg)